Skip to content

Assessment a method in the management of Myofascial pain dysfunction syndrome

Study on the effectiveness of 12.5 % dextrose with 2 % lignocaine (Prolotherapy) in comparison to 2% lignocaine alone in ultrasound-guided trigger point injection in the management of Myofascial pain dysfunction syndrome- Single blinded randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/059117
Enrollment
154
Registered
2023-10-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M628- Other specified disorders of muscle

Interventions

Intervention1: 12.5% Dextrose group-12.5% dextrose will be made by adding 1ml 2% lignocaine to 1ml 25% dextrose.: The trigger points will be marked with a marker. Pressure pain threshold and pain tole

Sponsors

Naqoosh Haidry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pure cases of MPDS without any joint pain MPDS in the masseter and temporalis muscle At least one active myofascial trigger point in the masseter and temporalis muscle Age-18 to 65 years old Cases who are not receiving any physical therapy or medication to relieve pain. MPDS cases non -respondent to other therapy

Exclusion criteria

Exclusion criteria: Cases of MPDS with temporomandibular joint pain. Active inflammatory, rheumatic, or infectious disease of TMJ Those who use anticoagulants, those with bleeding diathesis Patients diagnosed with fibromyalgia or other common musculoskeletal pain syndromes Patients with a history of panic attacks Those who are allergic to local anesthetic drug Those who are pregnant Patient with vitamin D deficiency

Design outcomes

Primary

MeasureTime frame
1) Pre and post-pain intensity by visual analog scale (VAS). 2) Pre and post-pressure pain threshold (The minimum pressure that induces pain in tissue trigger points)measured by algometer (kg/cm2). Timepoint: 4th week, 8th week

Secondary

MeasureTime frame
1)To assess Pain tolerance (The point where painful pressure stimulus cannot be tolerated)measurement. 2)To evaluate the range of mandibular movement (Mouth opening, Protrusive movement, Retrusive movement, Right Lateral movement, and Left Lateral movement). Timepoint: 4th week, 8th week

Countries

India

Contacts

Public ContactNaqoosh Haidry

All India institute of medical sciences

naqoosh.haidry@gmail.com7096843640

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026